The sale price is well below the 52-week high of $41.00 per share, thus suggesting an opportunistic purchase by Alcon. MONSEY, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of STAAR Surgical Company (Nasdaq: STAA) ("STAAR") to Alcon, Inc. ("Alcon") for $28.00 per share in cash. The sale price is well below the 52-week high of $41.00 per share, thus suggesting an opportunistic purchase by Alcon. Additionally, as further detailed ...